Le Lézard
Classified in: Health, Business
Subjects: CON, JVN

RenalSense Announces Distribution Agreement With Fresenius Medical Care


JERUSALEM, April 30, 2018 /PRNewswire/ --

RenalSense® has entered into an agreement with Fresenius Medical Care (Bad Homburg) for distribution of its Clarity RMS® critical care urine monitoring system in Europe, the Middle East, and Africa (EMEA). Fresenius Medical Care will market the company's products in 85 EMEA countries through its acute care division.

AKI occurs in over 55% of ICU patients, and is often associated with a high risk of chronic kidney disease, as well as increased morbidity and mortality. Clarity RMS®, which facilitates early detection of changes in renal function and Acute Kidney Injury (AKI) risk, is installed in a number of intensive care units in leading medical centers across the United States and Israel. The system continuously measures urine flow, automatically transmitting real-time data and alerts of fluctuations on a 24/7 basis to enable rapid intervention, monitoring of treatment efficacy and fluid management.

Fresenius Medical Care is the world's largest provider of products and services for patients with chronic renal failure. Through its network of more than 3,700 dialysis clinics worldwide, Fresenius Medical Care provides dialysis treatments for more than 320,000 patients. Fresenius Medical Care is also one of the world's leading providers of products for patients with acute renal failure. With an annual turnover of ?17.8B (2017), the company is traded on the Frankfurt (FWB: FME) and New York (NYSE:FMS) Stock Exchanges.

RenalSense® is a privately owned medical device company dedicated to real-time renal diagnostics. The company's first product, Clarity RMS®, provides continuous, automatic monitoring of urine flow, enabling better patient care and ICU economics. RenalSense's next generation products will provide additional real-time parameters and expanded diagnostic capabilities, to further improve the practice of ICU and critical care management.

For more information please contact:
Jean-Paul Benhamou
VP Sales and Marketing
Email: [email protected]
Website: http://www.renalsense.com

SOURCE RenalSense


These press releases may also interest you

at 11:18
Bloxcross, a premier payment solutions provider, and GoDirectPay, an e-payment expert, have collaborated to launch a groundbreaking mobile application that revolutionizes global payments. https://directpay.blox.global/register/ This custom-built app...

at 11:10
NewMarket Corporation announced today it expects to release first quarter 2024 earnings at the close of business on Wednesday, April 24, 2024. The earnings announcement will also be available on the Company's website at www.NewMarket.com the...

at 11:07
SOCOTEC USA, a leading provider of TIC (Testing, Inspection, and Certification), consulting, and advisory services with a strategic focus on buildings and infrastructure, announces its collaboration with Bisnow to deepen the understanding of the...

at 11:05
Knight Therapeutics Inc. ("Knight" or "the Company") is pleased to announce it will be recognized on The Globe and Mail's 2024 Report on Business magazine's fifth annual Women Lead Here list. This annual editorial benchmark identifies top-level...

at 11:01
Trading resumes in: Company: Horizonte Minerals Plc. TSX Symbol: HZM All Issues: Yes Resumption (ET): 11:00 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are...

at 11:00
Eagle Hill Consulting has earned another top workplace award, this time selected by The Washington Business Journal as a 2024 Best Places to Work in the extra-large sized company category. Eagle Hill also has earned multiple best workplace awards...



News published on and distributed by: